JP2016534134A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534134A5 JP2016534134A5 JP2016540436A JP2016540436A JP2016534134A5 JP 2016534134 A5 JP2016534134 A5 JP 2016534134A5 JP 2016540436 A JP2016540436 A JP 2016540436A JP 2016540436 A JP2016540436 A JP 2016540436A JP 2016534134 A5 JP2016534134 A5 JP 2016534134A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- alkyl
- cyano
- compound
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *#Cc(c([C@]1N=O)c2CC1(F)F)ccc2Oc1cc(F)cc(F)c1 Chemical compound *#Cc(c([C@]1N=O)c2CC1(F)F)ccc2Oc1cc(F)cc(F)c1 0.000 description 6
- ZGVWZAJMWJIHNT-HNNXBMFYSA-N CS(c(c([C@@H]1O)c2CC1(F)F)ccc2Oc1cc(F)cc(F)c1)(=O)=O Chemical compound CS(c(c([C@@H]1O)c2CC1(F)F)ccc2Oc1cc(F)cc(F)c1)(=O)=O ZGVWZAJMWJIHNT-HNNXBMFYSA-N 0.000 description 1
- YSQBDUMLHQLQBH-HPGBDJQBSA-N C[S@](c(cc1)c([C@@H](C(C2)(F)F)O)c2c1Oc1cc(C#N)cc(F)c1)(=NC#N)=O Chemical compound C[S@](c(cc1)c([C@@H](C(C2)(F)F)O)c2c1Oc1cc(C#N)cc(F)c1)(=NC#N)=O YSQBDUMLHQLQBH-HPGBDJQBSA-N 0.000 description 1
- KXKBSLFAMIIKMT-UHFFFAOYSA-N OC(C(Cc1c(cc2)Oc(cc3)c(cn[nH]4)c4c3F)(F)F)c1c2S(C(F)(F)F)(=O)=O Chemical compound OC(C(Cc1c(cc2)Oc(cc3)c(cn[nH]4)c4c3F)(F)F)c1c2S(C(F)(F)F)(=O)=O KXKBSLFAMIIKMT-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361875674P | 2013-09-09 | 2013-09-09 | |
| US61/875,674 | 2013-09-09 | ||
| US201461978421P | 2014-04-11 | 2014-04-11 | |
| US61/978,421 | 2014-04-11 | ||
| PCT/US2014/054375 WO2015035223A1 (en) | 2013-09-09 | 2014-09-05 | Aryl ethers and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019018100A Division JP6746733B2 (ja) | 2013-09-09 | 2019-02-04 | アリールエーテルおよびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534134A JP2016534134A (ja) | 2016-11-04 |
| JP2016534134A5 true JP2016534134A5 (enExample) | 2017-10-12 |
| JP6486940B2 JP6486940B2 (ja) | 2019-03-20 |
Family
ID=52628976
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540436A Active JP6486940B2 (ja) | 2013-09-09 | 2014-09-05 | アリールエーテルおよびその使用 |
| JP2019018100A Active JP6746733B2 (ja) | 2013-09-09 | 2019-02-04 | アリールエーテルおよびその使用 |
| JP2019052946A Pending JP2019089855A (ja) | 2013-09-09 | 2019-03-20 | アリールエーテルおよびその使用 |
| JP2019052947A Active JP6918039B2 (ja) | 2013-09-09 | 2019-03-20 | アリールエーテルおよびその使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019018100A Active JP6746733B2 (ja) | 2013-09-09 | 2019-02-04 | アリールエーテルおよびその使用 |
| JP2019052946A Pending JP2019089855A (ja) | 2013-09-09 | 2019-03-20 | アリールエーテルおよびその使用 |
| JP2019052947A Active JP6918039B2 (ja) | 2013-09-09 | 2019-03-20 | アリールエーテルおよびその使用 |
Country Status (33)
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015022096A8 (pt) | 2013-03-15 | 2019-11-26 | Chromocell Corp | compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos |
| SG11201601616SA (en) | 2013-09-09 | 2016-04-28 | Peloton Therapeutics Inc | Aryl ethers and uses thereof |
| CN105611923B (zh) | 2013-09-10 | 2019-08-23 | 卓莫赛尔公司 | 用于治疗疼痛和糖尿病的钠通道调节剂 |
| US9884843B2 (en) | 2013-12-16 | 2018-02-06 | Peloton Therapeutics, Inc. | Cyclic sulfone and sulfoximine analogs and uses thereof |
| EP3203991A4 (en) * | 2014-10-10 | 2018-06-20 | The Board of Regents of The University of Texas System | Hif-2 inhibitors for treating iron overload disorders |
| WO2016145236A1 (en) * | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Hif-2-alpha inhibitor polymorphs |
| US10278942B2 (en) | 2015-03-11 | 2019-05-07 | Peloton Therapeutics, Inc. | Compositions for use in treating pulmonary arterial hypertension |
| US10807948B2 (en) * | 2015-03-11 | 2020-10-20 | Peloton Therapeutics, Inc. | Aromatic compounds and uses thereof |
| WO2016145045A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Compositions for use in treating glioblastoma |
| WO2016144826A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Substituted pyridines and uses thereof |
| WO2016168510A1 (en) * | 2015-04-17 | 2016-10-20 | Peloton Therapeutics, Inc. | Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
| US9796697B2 (en) | 2015-06-12 | 2017-10-24 | Peloton Therapeutics, Inc. | Tricyclic inhibitors of HIF-2-alpha and uses thereof |
| CN105566406A (zh) * | 2015-12-30 | 2016-05-11 | 江西胜富化工有限公司 | 一种氟代脱氧呋喃核糖的制备方法 |
| WO2018031680A1 (en) * | 2016-08-10 | 2018-02-15 | Fronthera U.S. Pharmaceuticals Llc | Novel compounds, uses and methods for their preparation |
| CN110167939B (zh) * | 2017-01-11 | 2021-12-31 | 江苏豪森药业集团有限公司 | 吡咯并[2,3-c]吡啶类衍生物、其制备方法及其在医药上的应用 |
| WO2018160772A1 (en) | 2017-02-28 | 2018-09-07 | The United State Of America, As Represented By The Secretary, Department Of Health & Human Services | Method of treating obesity, insulin resistance, non-alcoholic fatty liver disease including non-alcoholic steatohepatitis |
| TWI642658B (zh) | 2017-11-01 | 2018-12-01 | 國立臺灣師範大學 | 茚並異喹啉衍生物的製備方法 |
| WO2019100053A1 (en) | 2017-11-20 | 2019-05-23 | University Of Georgia Research Foundation, Inc. | Compositions and methods for modulating hif-2α to improve muscle generation and repair |
| US20210015764A1 (en) * | 2018-03-28 | 2021-01-21 | Peloton Therapeutics Inc. | Methods of reducing inflammation of the digestive system with inhibitors of hif-2- alpha |
| EP3793989B1 (en) | 2018-05-18 | 2024-08-21 | Merck Patent GmbH | Thiophene derivatives |
| EP3849541A4 (en) | 2018-09-11 | 2022-06-22 | Nikang Therapeutics, Inc. | 2,3-DIHYDROBENZO[B]THIOPHENE DERIVATIVES AS HYPOXIA-INDUCABLE FACTOR-2 (ALPHA) INHIBITORS |
| US12077506B2 (en) | 2018-10-17 | 2024-09-03 | Nikang Therapeutics, Inc. | Indane derivatives as hypoxia inducible factor-2(α) inhibitors |
| SG11202104208RA (en) * | 2018-10-30 | 2021-05-28 | Peloton Therapeutics Inc | Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof |
| CN109776607B (zh) * | 2019-02-21 | 2021-06-04 | 青岛海洋生物医药研究院 | 芳基磷氧类和芳基磷硫类化合物及其制备方法和应用 |
| IL287258B2 (en) * | 2019-04-18 | 2026-01-01 | Nikang Therapeutics Inc | Inhibitors as tetrahydro-1h-cyclopenta[cd] indene derivatives as hypoxia inducible factor -2alpha |
| US12610949B2 (en) | 2019-07-23 | 2026-04-28 | Bayer Aktiengesellschaft | Heteroaryl-triazole compounds as pesticides |
| WO2021055728A1 (en) | 2019-09-18 | 2021-03-25 | Merck Sharp & Dohme Corp. | Small molecule inhibitors of kras g12c mutant |
| US11576889B2 (en) | 2019-09-23 | 2023-02-14 | The Board Of Regents Of The University Of Texas System | Methods of identifying and treating patients with HIF-2 inhibitor resistance |
| CA3158793A1 (en) | 2019-10-28 | 2021-05-06 | Merck Sharp & Dohme Corp. | Small molecule inhibitors of kras g12c mutant |
| JP2023515235A (ja) | 2019-10-31 | 2023-04-12 | 大鵬薬品工業株式会社 | ４－アミノブタ－２－エンアミド誘導体及びその塩 |
| CN112812136B (zh) * | 2019-11-15 | 2022-04-12 | 武汉光谷亚太医药研究院有限公司 | 新型2,3-二氢化茚衍生化合物、制备方法和应用 |
| TW202136248A (zh) | 2019-11-25 | 2021-10-01 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基-三唑化合物 |
| US12606537B2 (en) | 2019-11-26 | 2026-04-21 | Ryvu Therapeutics S.A. | Thiophene derivatives |
| WO2021106231A1 (en) | 2019-11-29 | 2021-06-03 | Taiho Pharmaceutical Co., Ltd. | A compound having inhibitory activity against kras g12d mutation |
| US20230024438A1 (en) * | 2019-12-04 | 2023-01-26 | Arcus Biosciences, Inc. | Inhibitors of hif-2alpha |
| CN111214484B (zh) * | 2020-01-21 | 2021-04-06 | 北京工商大学 | 一种共轭聚合物和聚集诱导发光小分子共掺的纳米粒子及其制备方法和应用 |
| CN113387848B (zh) * | 2020-03-12 | 2022-11-22 | 上海交通大学 | 一种制备磺酰胺类化合物的合成工艺 |
| IL295569B1 (en) * | 2020-03-19 | 2026-04-01 | Arcus Biosciences Inc | Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2ALPHA |
| US11420936B2 (en) | 2020-04-16 | 2022-08-23 | Nikang Therapeutics, Inc. | Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases |
| US20230174518A1 (en) | 2020-04-24 | 2023-06-08 | Taiho Pharmaceutical Co., Ltd. | Kras g12d protein inhibitors |
| WO2021215545A1 (en) | 2020-04-24 | 2021-10-28 | Taiho Pharmaceutical Co., Ltd. | Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl)-1h-imidazole-5-carboxamide inhibitor of kras-g12c |
| TWI891782B (zh) | 2020-05-06 | 2025-08-01 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基三唑化合物 |
| CA3186769A1 (en) * | 2020-06-11 | 2021-12-16 | Betta Pharmaceuticals Co., Ltd | Bicyclic compounds and use thereof |
| CN115667190B (zh) * | 2020-06-17 | 2024-10-11 | 贝达药业股份有限公司 | 双环类化合物及其应用 |
| JP7327855B2 (ja) | 2020-06-26 | 2023-08-16 | ラクオリア創薬株式会社 | レチノイドとがん治療薬との併用療法が有効ながん患者の選択方法およびレチノイドとがん治療薬との併用医薬 |
| JP7373664B2 (ja) | 2020-07-15 | 2023-11-02 | 大鵬薬品工業株式会社 | 腫瘍の治療に使用されるピリミジン化合物を含む組み合わせ |
| WO2022063115A1 (zh) * | 2020-09-24 | 2022-03-31 | 贝达药业股份有限公司 | 双环化合物及其应用 |
| WO2022082329A1 (en) * | 2020-10-19 | 2022-04-28 | Nikang Therapeutics, Inc. | Processes of preparing 3-fluoro-5- ( ( (1s, 2ar) -1, 3, 3, 4, 4-pentafluoro-2a-hydroxy-2, 2a, 3, 4-tetrahydro-1h-cyclopenta [cd] inden-7-yl) oxy) -benzonitrile |
| WO2022082337A1 (en) | 2020-10-19 | 2022-04-28 | Nikang Therapeutics, Inc. | Process of preparing 3-fluoro-5 ( ( (1r, 2ar) -3, 3, 4, 4-tetrafluoro-1, 2a-dihydroxy-2, 2a, 3, 4-tetrahydro-1h-cyclopenta [cd] inden-7-yl) oxy) benzonitrile |
| WO2022086882A1 (en) | 2020-10-21 | 2022-04-28 | Nikang Therapeutics, Inc. | Diagnostic and therapeutic methods for treatment of cancer with a hif-2(alpha) inhibitor |
| CN112724167B (zh) * | 2021-01-13 | 2022-11-11 | 湖北恒安芙林药业股份有限公司 | 一种克立硼罗的制备方法 |
| US11827614B2 (en) | 2021-05-21 | 2023-11-28 | Merck Sharp & Dohme Llc | Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates |
| WO2022250170A1 (en) | 2021-05-28 | 2022-12-01 | Taiho Pharmaceutical Co., Ltd. | Small molecule inhibitors of kras mutated proteins |
| CN113651735B (zh) * | 2021-08-27 | 2022-04-15 | 中国药科大学 | 一种HIF-2α抑制剂PT2385的制备方法 |
| US12145901B1 (en) | 2021-09-17 | 2024-11-19 | Arcus Biosciences, Inc. | Process for preparing tetralin compounds |
| EP4419089A4 (en) * | 2021-10-18 | 2025-09-10 | Nikang Therapeutics Inc | HYPOXIA-INDUCIBLE FACTOR 2-(ALPHA) INHIBITORS FOR THE TREATMENT OF BLADDER CANCER |
| WO2023160552A1 (zh) * | 2022-02-22 | 2023-08-31 | 南京明德新药研发有限公司 | 一类螺环类化合物及其应用 |
| CN116178223B (zh) * | 2022-04-15 | 2024-12-03 | 上海皓鸿生物医药科技有限公司 | 一种Belzutifan及其中间体的制备方法 |
| CN114656379B (zh) * | 2022-04-27 | 2024-06-04 | 成都道合尔医药技术有限公司 | 一种立他司特中间体的合成方法 |
| CN115611847B (zh) * | 2022-10-13 | 2024-04-30 | 南方科技大学坪山生物医药研究院 | 一种Belzutifan的中间体的制备方法 |
| WO2024104932A1 (en) * | 2022-11-14 | 2024-05-23 | F. Hoffmann-La Roche Ag | Aryl thioethers as hif-2alpha inhibitors |
| TWI899933B (zh) | 2023-04-06 | 2025-10-01 | 美商輝瑞大藥廠 | 經取代吲唑丙酸衍生化合物及其用途 |
| WO2025043187A1 (en) | 2023-08-24 | 2025-02-27 | Otsuka Pharmaceutical Co., Ltd. | Fixed dose combinations of cedazuridine and azacitidine |
| WO2025085748A1 (en) | 2023-10-20 | 2025-04-24 | Merck Sharp & Dohme Llc | Small molecule inhibitors of kras proteins |
| CN118005840B (zh) * | 2024-04-08 | 2024-06-14 | 西南石油大学 | 一种热增稠自破胶压裂液稠化剂及其制备方法和应用 |
| CN121449535B (zh) * | 2025-12-31 | 2026-04-21 | 淄博飞源化工有限公司 | 光催化合成三氟甲磺酸的方法 |
Family Cites Families (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE705530C (de) | 1932-01-23 | 1941-04-30 | Chem Fab Von Heyden Akt Ges | Verfahren zur Darstellung von Polychlorsubstitutionsprodukten des Diphenylaethers |
| FR1574139A (enExample) | 1968-05-06 | 1969-07-11 | ||
| US3905971A (en) * | 1971-03-29 | 1975-09-16 | Pfizer | 2-Phenyl-as-triazine-3,5(2H,4H)diones |
| JPS4872169A (enExample) | 1971-12-28 | 1973-09-29 | ||
| GB1448696A (en) * | 1973-05-29 | 1976-09-08 | Pfizer | 2-phqnyl-astriazine-3,4-2h,4h-diones |
| GB2017087B (en) | 1978-03-03 | 1982-09-02 | Roussel Lab Ltd | Process for the preparation of xanthone derivatives |
| US4214103A (en) | 1978-11-30 | 1980-07-22 | Great Lakes Chemical Corporation | Purification of brominated organic products |
| DE2938595A1 (de) | 1979-09-24 | 1981-04-23 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Verfahren zur herstellung von diphenylaethern |
| US4505929A (en) | 1980-06-12 | 1985-03-19 | The Dow Chemical Company | Sulfur-substituted diphenyl ethers having antiviral activity |
| US4426385A (en) * | 1980-10-16 | 1984-01-17 | Union Carbide Corporation | Insecticidal bicyclooxyphenyl ureas |
| DE3110894A1 (de) * | 1981-03-20 | 1982-09-30 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Neue nitroaniline |
| DE3239449A1 (de) | 1981-10-27 | 1983-05-05 | CIBA-GEIGY AG, 4002 Basel | Phenoxyphenyl- und pyridyloxyphenyl-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung |
| JPS58124758A (ja) * | 1982-01-20 | 1983-07-25 | Fujisawa Pharmaceut Co Ltd | ベンゼンスルホンアミド誘導体 |
| DE3209878A1 (de) * | 1982-03-18 | 1983-09-29 | Celamerck Gmbh & Co Kg, 6507 Ingelheim | Verfahren zur herstellung von diphenylaethern |
| US4665097A (en) * | 1983-03-31 | 1987-05-12 | Union Carbide Corporation | Novel bicyclooxyaryl thioureas and process for preparation |
| US4664097A (en) | 1984-05-09 | 1987-05-12 | The Wistar Institute Of Anatomy & Biology | Nuclear transplantation in the mammalian embryo by microsurgery and cell fusion |
| US4705955A (en) * | 1985-04-02 | 1987-11-10 | Curt Mileikowsky | Radiation therapy for cancer patients |
| JPS635136A (ja) | 1986-06-26 | 1988-01-11 | Mitsubishi Electric Corp | 内燃機関のアイドル回転数制御装置 |
| JPS6351363A (ja) | 1986-08-21 | 1988-03-04 | Tekukemu:Kk | アミノ基を有するジフエニ−ル化合物の製造方法 |
| US5059609A (en) | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| IL105777A0 (en) * | 1992-06-04 | 1993-09-22 | Great Lakes Chemical Corp | Method for the isolation of a partially brominated diphenyl ether product |
| EP0640618B1 (de) | 1993-08-27 | 1999-10-20 | F. Hoffmann-La Roche Ag | Tetrahydronaphthalin-Peptidderivate |
| DE4431219A1 (de) * | 1994-09-02 | 1996-03-07 | Bayer Ag | Selektive Herbizide auf Basis von Aryluracilen |
| DE69634639T2 (de) | 1995-12-06 | 2006-03-02 | Japan Science And Technology Agency, Kawaguchi | Verfahren zur herstellung optische aktive verbindungen |
| US6887820B1 (en) | 1995-12-06 | 2005-05-03 | Japan Science And Technology Corporation | Method for producing optically active compounds |
| WO1998042671A1 (de) | 1997-03-20 | 1998-10-01 | Basf Aktiengesellschaft | Substituierte 2-benz(o)ylpyridin derivate, deren herstellung und deren verwendung als herbizide |
| CA2382789A1 (en) | 1999-08-27 | 2001-03-08 | Sugen, Inc. | Phosphate mimics and methods of treatment using phosphatase inhibitors |
| DE60234100D1 (de) | 2001-04-24 | 2009-12-03 | Vlaams Interuniv Inst Biotech | Verwendung von "hypoxia inducible factor 2alpha" zur behandlung von "neonatal respiratory distress syndrome" |
| EP1471049A4 (en) * | 2002-01-30 | 2006-08-16 | Kissei Pharmaceutical | NEW THYROIDIAN HORMONE RECEPTOR LIGAND, MEDICINAL PREPARATIONS CONTAINING THE SAME AND USE THEREOF |
| CA2463464A1 (en) | 2003-04-28 | 2004-10-28 | Auckland Uniservices Limited | Methods of treatment and compositions therefor |
| SE0301906D0 (sv) * | 2003-06-26 | 2003-06-26 | Astrazeneca Ab | New compounds |
| US7728025B2 (en) | 2003-12-29 | 2010-06-01 | Banyu Pharmaceutical Co., Ltd. | 2-heteroaryl-substituted benzimidazole derivative |
| CA2568165A1 (en) | 2004-05-28 | 2005-12-15 | Speedel Experimenta Ag | Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| CA2580024A1 (en) | 2004-09-10 | 2006-03-16 | Pfizer Products Inc. | Therapeutic diphenyl ether ligands |
| US7576094B2 (en) | 2004-12-13 | 2009-08-18 | Eli Lilly And Company | Spiro derivatives as lipoxygenase inhibitors |
| US7759493B2 (en) | 2005-01-31 | 2010-07-20 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| TW200714597A (en) | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| EP1940781A1 (en) | 2005-10-19 | 2008-07-09 | F.Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
| AU2006323700B2 (en) * | 2005-12-05 | 2011-02-17 | Otsuka Pharmaceutical Co., Ltd. | Diarylether derivatives as antitumor agents |
| US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| GB0526445D0 (en) | 2005-12-23 | 2006-02-08 | Novartis Ag | Organic compounds |
| EP1976828B1 (en) | 2005-12-29 | 2016-12-21 | Celtaxsys, Inc. | Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| WO2007099423A1 (en) | 2006-03-02 | 2007-09-07 | Pfizer Products Inc. | 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists |
| US20070244071A1 (en) * | 2006-03-07 | 2007-10-18 | Mount Sinai Hospital | Treatment of proliferative diseases |
| ATE552245T1 (de) * | 2006-05-15 | 2012-04-15 | Merck Sharp & Dohme | Antidiabetische bicyclische verbindungen |
| WO2008024438A2 (en) * | 2006-08-23 | 2008-02-28 | Neurogen Corporation | 2-phenoxy pyrimidinone analogues |
| CA2682377A1 (en) | 2007-03-30 | 2008-10-09 | Nippon Shinyaku Co., Ltd. | Heteroaryl derivatives |
| CN101058535B (zh) | 2007-05-25 | 2010-07-21 | 复旦大学 | 二(7-羟基-2,3-二氢-1-1h-茚基)醚类及其类似物、合成方法及应用 |
| ATE478053T1 (de) * | 2007-06-06 | 2010-09-15 | Torrent Pharmaceuticals Ltd | Neuartige verbindungen |
| WO2008157273A1 (en) | 2007-06-14 | 2008-12-24 | Smithkline Beecham Corporation | Chemical compounds |
| CN101407467A (zh) * | 2007-10-12 | 2009-04-15 | 中国人民解放军军事医学科学院毒物药物研究所 | N-取代芳烃苯胺/多取代二芳基醚类化合物,其制备方法及抗肿瘤应用 |
| CA2705489A1 (en) * | 2007-12-05 | 2009-06-11 | Basf Se | Pyridylmethyl-sulfonamide compounds |
| WO2009093133A1 (en) | 2008-01-25 | 2009-07-30 | Medichem, S.A. | Method for determining the enantiomeric purity of indane derivatives |
| KR20100119825A (ko) | 2008-03-05 | 2010-11-10 | 에프. 호프만-라 로슈 아게 | 2-아미노퀴놀린 |
| US8188098B2 (en) | 2008-05-19 | 2012-05-29 | Hoffmann-La Roche Inc. | GPR119 receptor agonists |
| AR074210A1 (es) * | 2008-11-24 | 2010-12-29 | Boehringer Ingelheim Int | Derivados de pirimidina como inhibidores de ptk2-quinasa |
| US8691866B2 (en) | 2008-12-10 | 2014-04-08 | The General Hospital Corporation | HIF inhibitors and use thereof |
| HUE025013T2 (hu) * | 2009-01-12 | 2016-04-28 | Pfizer Ltd | Szulfonamid-származékok |
| EP2406230A1 (en) | 2009-03-11 | 2012-01-18 | Pfizer Inc. | Substituted indazole amides and their use as glucokinase activators |
| WO2010137620A1 (ja) | 2009-05-27 | 2010-12-02 | 武田薬品工業株式会社 | フェノキシエチルアミン誘導体 |
| ES2693687T3 (es) | 2009-06-05 | 2018-12-13 | Joan M. Caron | Compuestos y composiciones para uso en el tratamiento del cáncer |
| US8461164B2 (en) | 2009-08-31 | 2013-06-11 | Dow Agrosciences, Llc. | Pteridines and their use as agrochemicals |
| US8716286B2 (en) | 2009-10-30 | 2014-05-06 | Glaxo Group Limited | Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione |
| US8853277B2 (en) * | 2009-11-30 | 2014-10-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC) |
| WO2011105603A1 (ja) | 2010-02-26 | 2011-09-01 | 株式会社日本触媒 | フタロシアニン誘導体 |
| GB201005589D0 (en) * | 2010-04-01 | 2010-05-19 | Respivert Ltd | Novel compounds |
| EP2556068B1 (en) | 2010-04-08 | 2019-01-23 | Respivert Limited | P38 map kinase inhibitors |
| US9062072B2 (en) | 2010-04-20 | 2015-06-23 | Emory University | Inhibitors of HIF and angiogenesis |
| US8853423B2 (en) | 2010-06-17 | 2014-10-07 | Seragon Pharmaceuticals, Inc. | Indane estrogen receptor modulators and uses thereof |
| DK2599774T3 (en) | 2010-07-29 | 2016-10-24 | Astellas Pharma Inc | DEHYDRATED pyridine AS CB2 cannabinoid receptor ligands |
| EP2502917A1 (en) | 2011-03-17 | 2012-09-26 | Santhera Pharmaceuticals (Schweiz) AG | Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole |
| EP3251671A1 (en) | 2011-06-06 | 2017-12-06 | Akebia Therapeutics Inc. | Compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer |
| UY34200A (es) | 2011-07-21 | 2013-02-28 | Bayer Ip Gmbh | 3-(fluorovinil)pirazoles y su uso |
| EP2758389B1 (en) | 2011-09-22 | 2017-06-07 | Merck Sharp & Dohme Corp. | Pyrazole carboxamides as janus kinase inhibitors |
| WO2013057101A1 (de) | 2011-10-17 | 2013-04-25 | Bayer Intellectual Property Gmbh | Substituierte oxadiazolylpyridinone und - pyridazinone als hif - hemmer |
| JP6014155B2 (ja) * | 2011-10-31 | 2016-10-25 | ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用 |
| CN104080773B (zh) | 2012-01-28 | 2016-12-28 | 默克专利股份公司 | 氮杂环化合物 |
| JP6198715B2 (ja) | 2012-03-06 | 2017-09-20 | 武田薬品工業株式会社 | 三環性化合物 |
| ME02753B (me) | 2012-06-21 | 2018-01-20 | Eisai R&D Man Co Ltd | Novi derivati indansulfamida |
| WO2014031933A2 (en) | 2012-08-24 | 2014-02-27 | Philip Jones | Heterocyclic modulators of hif activity for treatment of disease |
| US20140073634A1 (en) | 2012-08-24 | 2014-03-13 | Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center | Heterocyclic modulators of hif activity for treatment of disease |
| US20140128365A1 (en) | 2012-11-02 | 2014-05-08 | Bristol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| EP2919770A4 (en) | 2012-11-14 | 2017-03-08 | The Board of Regents of The University of Texas System | Inhibition of hif-2 heterodimerization with hif1 (arnt) |
| HK1210144A1 (en) * | 2012-11-28 | 2016-04-15 | 勃林格殷格翰国际有限公司 | New indanyloxydihydrobenzofuranylacetic acids |
| US20140163025A1 (en) * | 2012-12-07 | 2014-06-12 | Boehringer Ingelheim International Gmbh | Indanyloxydihydrobenzofuranylacetic acids |
| SG11201601616SA (en) | 2013-09-09 | 2016-04-28 | Peloton Therapeutics Inc | Aryl ethers and uses thereof |
| US9884843B2 (en) | 2013-12-16 | 2018-02-06 | Peloton Therapeutics, Inc. | Cyclic sulfone and sulfoximine analogs and uses thereof |
| US10807948B2 (en) | 2015-03-11 | 2020-10-20 | Peloton Therapeutics, Inc. | Aromatic compounds and uses thereof |
| WO2016145045A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Compositions for use in treating glioblastoma |
| WO2016145236A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Hif-2-alpha inhibitor polymorphs |
| US10278942B2 (en) | 2015-03-11 | 2019-05-07 | Peloton Therapeutics, Inc. | Compositions for use in treating pulmonary arterial hypertension |
| WO2016144826A1 (en) | 2015-03-11 | 2016-09-15 | Peloton Therapeutics, Inc. | Substituted pyridines and uses thereof |
| WO2016168510A1 (en) | 2015-04-17 | 2016-10-20 | Peloton Therapeutics, Inc. | Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
| US9796697B2 (en) | 2015-06-12 | 2017-10-24 | Peloton Therapeutics, Inc. | Tricyclic inhibitors of HIF-2-alpha and uses thereof |
-
2014
- 2014-09-05 SG SG11201601616SA patent/SG11201601616SA/en unknown
- 2014-09-05 CN CN201910648122.4A patent/CN110372550B/zh active Active
- 2014-09-05 EP EP18185565.1A patent/EP3417852B1/en active Active
- 2014-09-05 CA CA2919397A patent/CA2919397C/en active Active
- 2014-09-05 JP JP2016540436A patent/JP6486940B2/ja active Active
- 2014-09-05 ES ES18185557T patent/ES2823477T3/es active Active
- 2014-09-05 SI SI201431659T patent/SI3417851T1/sl unknown
- 2014-09-05 LT LTEP18185557.8T patent/LT3417851T/lt unknown
- 2014-09-05 MX MX2016002974A patent/MX2016002974A/es unknown
- 2014-09-05 CN CN201480049731.3A patent/CN105530923B/zh active Active
- 2014-09-05 MY MYPI2019004945A patent/MY199426A/en unknown
- 2014-09-05 SI SI201431262T patent/SI3043784T1/sl unknown
- 2014-09-05 KR KR1020167009164A patent/KR102153772B1/ko active Active
- 2014-09-05 PL PL18185557T patent/PL3417851T3/pl unknown
- 2014-09-05 AU AU2014318025A patent/AU2014318025B2/en active Active
- 2014-09-05 EP EP14842085.4A patent/EP3043784B9/en active Active
- 2014-09-05 SM SM20190479T patent/SMT201900479T1/it unknown
- 2014-09-05 HU HUE14842085A patent/HUE045462T2/hu unknown
- 2014-09-05 RS RS20201258A patent/RS60953B1/sr unknown
- 2014-09-05 PT PT14842085T patent/PT3043784T/pt unknown
- 2014-09-05 HR HRP20191298TT patent/HRP20191298T1/hr unknown
- 2014-09-05 RS RS20190855A patent/RS58960B1/sr unknown
- 2014-09-05 DK DK14842085.4T patent/DK3043784T3/da active
- 2014-09-05 EP EP19192594.0A patent/EP3586835B1/en active Active
- 2014-09-05 EA EA201690549A patent/EA032124B1/ru unknown
- 2014-09-05 US US14/905,776 patent/US9908845B2/en active Active
- 2014-09-05 PL PL14842085T patent/PL3043784T3/pl unknown
- 2014-09-05 EP EP18185557.8A patent/EP3417851B1/en active Active
- 2014-09-05 CU CU2016000030A patent/CU24385B1/es unknown
- 2014-09-05 HR HRP20201701TT patent/HRP20201701T8/hr unknown
- 2014-09-05 PT PT181855578T patent/PT3417851T/pt unknown
- 2014-09-05 BR BR112016005262-5A patent/BR112016005262B1/pt active IP Right Grant
- 2014-09-05 WO PCT/US2014/054375 patent/WO2015035223A1/en not_active Ceased
- 2014-09-05 ES ES14842085T patent/ES2739433T3/es active Active
- 2014-09-05 HU HUE18185557A patent/HUE052080T2/hu unknown
- 2014-09-05 LT LTEP14842085.4T patent/LT3043784T/lt unknown
- 2014-09-05 PE PE2016000342A patent/PE20160434A1/es unknown
- 2014-09-05 ES ES18185565T patent/ES2784454T3/es active Active
- 2014-09-09 TW TW103131075A patent/TWI657071B/zh active
- 2014-09-09 TW TW108108484A patent/TW201936572A/zh unknown
- 2014-09-09 UY UY0001035731A patent/UY35731A/es active IP Right Grant
-
2016
- 2016-02-01 IL IL243888A patent/IL243888B/en active IP Right Grant
-
2017
- 2017-02-22 US US15/439,494 patent/US9896418B2/en active Active
- 2017-02-22 US US15/439,308 patent/US9969689B2/en not_active Ceased
- 2017-11-07 US US15/805,390 patent/US10144711B2/en active Active
-
2018
- 2018-10-18 US US16/164,653 patent/US10597366B2/en active Active
-
2019
- 2019-02-04 JP JP2019018100A patent/JP6746733B2/ja active Active
- 2019-03-20 JP JP2019052946A patent/JP2019089855A/ja active Pending
- 2019-03-20 JP JP2019052947A patent/JP6918039B2/ja active Active
- 2019-08-07 CY CY20191100842T patent/CY1122144T1/el unknown
-
2020
- 2020-02-20 US US16/795,697 patent/US20200190031A1/en not_active Abandoned
- 2020-10-06 CY CY20201100939T patent/CY1123433T1/el unknown
-
2022
- 2022-02-03 US US17/592,108 patent/USRE49948E1/en active Active
-
2025
- 2025-05-05 FI FIC20253001C patent/FIC20253001I1/fi unknown
- 2025-05-06 NL NL301327C patent/NL301327I2/nl unknown
- 2025-05-12 NO NO2025022C patent/NO2025022I1/no unknown
- 2025-05-13 HU HUS2500021C patent/HUS2500021I1/hu unknown
- 2025-05-14 LT LTPA2025519C patent/LTPA2025519I1/lt unknown
- 2025-05-19 FR FR25C1018C patent/FR25C1018I2/fr active Active
- 2025-05-30 CY CY2025017C patent/CY2025017I1/el unknown